Bifogade filer
Finalization of share buyback program in Initiator Pharma
Kurs & Likviditet
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Initiator Pharma via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Beskrivning
| Land | Danmark |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
2022-07-22 11:45:00
Initiator Pharma A/S (“Initiator” or the “Company”) has today finalized the share buyback that was announced on 22 June 2022
Today Initiator has finalized the buyback of shares that was announced on 22 June 2022 and prolonged on 14 July 2022. In connection with the buy back, the Company has bought a total of 24,000 shares (“Treasury Shares”) at an average price of SEK 7.36.
Initiator has sold the Treasury Shares to certain members of the Board of Directors under the LTI2021-program. Each share was sold at a price of DKK 0.105 per share corresponding to par value.
The aggregate proceeds from the sale of treasury shares are DKK 2,520.